The current state of knowledge on the use of the benchmark dose concept in risk assessment¶
Sand, V., & Filipsson. (2007). The current state of knowledge on the use of the benchmark dose concept in risk assessment.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Domain-specific¶
- NOAEL (No Observed Adverse Effect Level)
- The NOAEL remains in widespread regulatory use, however, because the existing toxicological database was built under the NOAEL framework and agencies require continuity with decades of prior regulatory decisions
This sourceA review of the benchmark-dose literature setting out the arguments in favour of the BMD over the NOAEL; whether it states the regulatory-continuity rationale for the NOAEL's persistence could not be checked against the full text.
- The NOAEL remains in widespread regulatory use, however, because the existing toxicological database was built under the NOAEL framework and agencies require continuity with decades of prior regulatory decisions
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:03574242ec70 · see in the full table